Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

BMB. 2019; 4(2): 42-48


The Effect of Nebivolol on Subarachnoid Hemorrhage-induced Vasospasm in the rabbit.

ILKER GULEC,ALI NAIL IZGI.




Abstract

Objective: This study aimed to investigate the vasorelaxation effect of nebivolol on vasospasm in the rabbit model of Subarachnoid Hemorrhage (SAH).
Material and Methods: Single-hemorrhage model in the rabbit SAH was employed. SAH was induced in animals by cisterna manga injection of 4 mL autologous blood. Thirty-two animals were categorized into four groups: 1) control group (no SAH), 2) SAH group, 3) SAH + solvent infused group and 4) SAH+ nebivolol treatment group.
Forty-Eight hours after SAH-induction, rabbits in group 3 and in 4 were received solvent or nebivolol, respectively. Nebivolol (0,073 mg/kg) was administered via the vertebral artery in 5 minutes. Digital subtraction angiography was performed at Forty-nine hour following SAH-induced groups. The diameters of basilar arteries in four groups were measured at three points, and the average of the measurements is accepted as a consecutive result.
Results: SAH-induced rats demonstrated severe vasospasm on day 2. Angiographic vasospasm was present in group 2 (SAH only), and in 3 (SAH plus solvent). Animals in group 4 (SAH plus nebivolol) and group 1 (control), respectively, demonstrated the largest diameters of basilar arteries. Animals treated with nebivolol has reached eighty-eight percent of the value in the control group 1. There was no statistical difference between the control group and SAH plus nebivolol treatment group (p>0.05). However, the difference was obtained between the groups SAH plus solvent and SAH plus nebivolol treatment (p

Key words: nebivolol; subarachnoid Hemorrhage; vasospasm; rabbit






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.